Standpoint Research
http://www.standpointresearch.comStandpoint Research provides independent equity research that is free from the conflicts of asset management, investment banking, proprietary trading, and fee-for-research arrangements. We provide thorough analysis, diagnostics and forecasts on domestic and international equities and markets backed by alpha-generating variables back-tested on many years of data. Standpoint Research currently advises and sells its research to pension funds, hedge funds and asset management firms. Wall Street analysts have an optimistic bias, while we are more objective. In fact some of the variables in our model that are looked at as positives by Wall Street actually carry negative weight in our model. We have a strict discipline that includes running our proprietary 155-variable valuation and diagnostics model with a personal and subjective overlay that has been proven to add value. The effectiveness is demonstrated through our impressive six-year track record of more than 300 recommendations.
View Older Stories View More Recent Stories
-
Standpoint Research Cuts Pfizer (PFE) to Hold Following Q3 Report
-
Standpoint Research Starts Spectrum Brands (SPB) at Buy; Oversold
-
Standpoint Research Cuts Freeport-McMoRan (FCX) to Hold
-
Standpoint Research Downgrades Jacobs Engineering (JEC) to Hold
-
Standpoint Research Downgrades International Bancshares (IBOC) to Hold
-
Standpoint Research Downgrades Chevron (CVX) to Hold
-
Standpoint Research Downgrades True Religion Apparel (TRLG) to Hold
-
Standpoint Research Downgrades Foster Wheeler (FWLT) to Hold
-
Standpoint Research Downgrades Posco (PKX) to Hold
-
Standpoint Research Upgrades Walgreen (WAG) to Buy
-
Standpoint Research Downgrades Volterra Semiconductor (VLTR) to Hold; Shares Looking Fairly Valued
-
Standpoint Cuts Quest Diagnostics (DGX) to Hold
-
Standpoint Research Downgrades Prosperity Bancshares (PRSP) to Hold
-
Standpoint Research Downgrades Symantec (SYMC) to Hold
-
Standpoint Research Downgrades Triumph Group (TGI) to Hold
-
Standpoint Research Downgrades W.R. Berkley (WRB) to Hold
-
Standpoint Research Downgrades National-Oilwell Varco (NOV) to Hold
-
Standpoint Research Downgrades Tempur-Pedic (TPX) to Hold
-
Standpoint Research Downgrades FedEx (FDX) to Hold
-
Standpoint Research Downgrades Gilead Sciences (GILD) to Hold
-
Notable Analyst Rating Changes 10/18: (VMW) (APC) (CROX) Upgraded; (SQNM) (AONE) (WAG) Downgraded
-
Standpoint Research Upgrades Crocs (CROX) to Buy
-
Standpoint Research Starts Foster Wheeler (FWLT) at Buy
-
Standpoint Research Downgrades Siemens (SI) to Hold
-
Standpoint Research Downgrades Crocs (CROX) to Hold
-
Standpoint Research Starts National-Oilwell Varco (NOV) at Buy
-
Standpoint Research Upgrades Crocs (CROX) to Buy
-
Standpoint Research Downgrades Wal-Mart (WMT) to Hold; Shifting Attention to Names with More Attractive P/E/G Ratios
-
Standpoint Research Upgrades Freeport-McMoRan (FCX) to Buy
-
Standpoint Research Cuts Intel (INTC) to Hold
-
Standpoint Research Downgrades Crocs (CROX) to Hold
-
Standpoint Research Upgrades Tempur-Pedic (TPX) to Buy
-
Standpoint Research Upgrades Lockheed Martin (LMT) to Buy
-
Standpoint Research Upgrades FedEx (FDX) to Buy
-
Standpoint Research Upgrades Sabesp (SBS) to Buy
-
Standpoint Research Upgrades MetroPCS (PCS) to Buy
-
Standpoint Research Upgrades Prosperity Bancshares (PRSP) to Buy
-
Standpoint Research Downgrades Tempur-Pedic (TPX) to Hold
-
Standpoint Research Starts First Solar (FSLR) at Buy
-
Standpoint Research Starts Siemens (SI) at Accumulate; The GE of Germany Trading at a Discount
-
Standpoint Cuts Microsoft (MSFT), Amgen (AMGN) to Hold
-
Standpoint Research Upgrades Volterra Semiconductor (VLTR) to Buy; Valuation Call
-
Standpoint Research Upgrades Cia Energetica de Minas Gerais (CIG) to Buy
-
Standpoint Research Upgrades Energizer (ENR) to Buy; Shares Currently Undervalued
-
Standpoint Research Downgrades MetroPCS (PCS) to Hold
-
Standpoint Research Downgrades Coventry Health Care (CVH) to Hold
-
Standpoint Research Downgrades Sabesp (SBS) to Hold
-
Standpoint Research Downgrades Energizer (ENR) to Hold
-
Standpoint Research Starts Tempur-Pedic (TPX) at Buy
-
Standpoint Research Upgrades ManTech (MANT) to Buy; Recent Dip Makes Shares Look Attractive

